e-learning
resources
ERJ
2008
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma
Kraft M., Adler K. B., Ingram J. L., Crews A. L., Atkinson T. P., Cairns C. B., Krause D. C., Chu H. W.
Source:
Eur Respir J 2008; 31: 43-46
Journal Issue:
January
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kraft M., Adler K. B., Ingram J. L., Crews A. L., Atkinson T. P., Cairns C. B., Krause D. C., Chu H. W.. Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma. Eur Respir J 2008; 31: 43-46
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Chlamydia pneumoniae
persists in COPD lung tissue: predominant role of toll-like receptor 2 versus 4 in
chlamydia pneumoniae
-induced activation of pulmonary immune cells
Source: Eur Respir J 2004; 24: Suppl. 48, 240s
Year: 2004
Vitamin D-mediated expression of the antimicrobial peptide hCAP18/LL-37 and killing of non-typeable haemophilus influenzae (NTHi) is reduced after 14 days exposure to TNF-α and IL-1β in primary bronchial epithelial cells (PBEC)
Source: International Congress 2015 – The multiple faces of host defense
Year: 2015
Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-?B and EGFR pathways
Source: Eur Respir J 2010; 36: 1425-1435
Year: 2010
Exposure of a bronchial epithelial cell line (BEAS-2B) to
haemophilus influenzae
(NTHi) lysate increases TLR-2 and TNF-α synthesis and results in an enhanced PMN adherence to epithelial cells
Source: Annual Congress 2008 - Airway infection and host defence
Year: 2008
Coinfection of
chlamydia pneumoniae
and
haemophilus influenzae
enhances interleukin-8 (IL-8) production in human macrophages and alveolar epithelial cells
Source: Eur Respir J 2007; 30: Suppl. 51, 405s
Year: 2007
Streptococcus pneumoniae-induced regulation of cyclooxygenase-2 in human lung tissue
Source: Eur Respir J 2012; 40: 1458-1467
Year: 2012
Chlamydia pneumoniae enhances infection with Haemophilus influenzae, up-regulates TLR2-expression in human lung tissue and leads to enhanced chemokine production after coinfection – a possible mechanism for COPD exacerbations
Source: Annual Congress 2008 - New diagnostic methods in viral and atypical infections
Year: 2008
Nontypeable Haemophilus influenzae infection of human lung tissue induces proinflammatory cytokine response via toll-like receptor 2 and EGF-receptor
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Inhibitory effects of tiotropium on rhinovirus infection in human airway epithelial cells
Source: Eur Respir J 2012; 40: 122-132
Year: 2012
The
moraxella catarrhalis
induced inflammatory response of pulmonary epithelial cells is mediated by activation of EGFR
Source: Annual Congress 2008 - Airway infection and host defence
Year: 2008
A subset of COPD patients defined by lung epithelial IL-6 trans-signalling is associated with neutrophilic inflammation and colonization by Haemophilus influenzae
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Antiapoptotic and proinflammatory function of toll-like receptor 2 in acute
C. pneumoniae
infection of COPD lung tissue
Source: Eur Respir J 2006; 28: Suppl. 50, 575s
Year: 2006
Cigarette smoke augments MUC5AC mucin production via TLR3-EGFR pathway in airway epithelial cells
Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung
Year: 2013
Chlamydia pneumoniae persists in TLR2 positive alveolar epithelial cells type II and alveolar macrophages of COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 350s
Year: 2003
Cross-talk between human lung fibroblasts and bronchial epithelial cells regulates MUC5AC and MUC5B production
Source: Annual Congress 2010 - Epithelial cells: cell biology and role in lung disease
Year: 2010
Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma
Source: Eur Respir J 2002; 20: 834-840
Year: 2002
Interleukin production by airway epithelial cells after
h. influenzae
exposure is not related to bacterial growth or passage
Source: Annual Congress 2004 - Community acquired pneumonia - epidemiology and host defence
Year: 2004
LSC - 2020 - Streptococcus pneumoniae induces broad alterations in mitochondrial functions in human airway epithelial cells
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
Fluticasone propionate decreases MUC5AC expression on airway epithelial cells induced by rhinovirus infection in the airway
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells
Source: Eur Respir J 2011; 37: 53-64
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept